Broadcast Date: Tuesday, June 21, 2022
from 3:00 pm to 4:30 pm (ET)


Antitrust litigation in the life sciences sector has continued to grow and evolve, with a rapid mix of innovate theories and impactful court decisions over the past few years.  Pharmaceutical companies must constantly consider the changing landscape as they pursue their business strategies to avoid legal pitfalls, and attorneys must stay up-to-date on decisions and strategies that are shaping the next generation of litigation.

Listen as a panel of distinguished thought leaders organized by The Knowledge Group provide the audience with an in-depth discussion of the trends, developments, and critical issues surrounding pharmaceutical antitrust matters.  Our panel will provide the audience with insight on recent cases that are shaping the litigation battlefields of tomorrow, as well as thoughtful analysis of the key issues that separate the cases.  Using a phased approach, they will walk you through the background of these key cases, and separate out the implications for class certification, merits issue, and how expert testimony can be used most effectively.

Key topics that will be discussed in this course are:

  • Recent Pharmaceutical Antitrust Cases: An Overview
  • Critical Issues and Challenges in Class Certification
  • Considerations for Complex Merits Issues
  • Practical Guidance for Lifecycle Management
  • Implications for Expert Testimony
  • What Lies Ahead


Course Level:



Advance Preparation:

Print and review course materials


Method of Presentation:

On-demand Webcast (CLE)



General knowledge of antitrust laws


Course Code:



NY Category of CLE Credit:

Areas of Professional Practice


Total Credits:

1.5 CLE

Speaker Panel:

David Shotlander, Partner
Haug Partners LLP

David Shotlander is an antitrust Partner in the Washington, D.C. office of Haug Partners, focusing his practice on antitrust litigation, government investigations and counseling. Mr. Shotlander has a strong background in industrial economics and has provided antitrust and litigation services to corporate clients for over a decade – a mix of skill and experience that enables him to pointedly and successfully address the questions and problems faced by his clients. Mr. Shotlander has represented branded and generic pharmaceutical companies on matters involving critical and emerging antitrust issues, including “reverse payment” litigation. He has also represented parties in merger and civil non-merger investigations before the Federal Trade Commission, Department of Justice and state attorney generals, as well as foreign competition authorities.

Pavel Darling, Vice President
Analysis Group, Inc.

Pavel Darling, a Vice President in Analysis Group’s Boston office, provides consulting and expert testimony support in complex litigation matters. He has performed quantitative analyses to address litigation, strategy, and policy questions, primarily in the health care industry, and has extensive experience with a range of sophisticated economic modeling tools and techniques. Mr. Darling’s healthcare work frequently deals with antitrust issues including pharmaceutical reverse payment settlements, intellectual property and patent infringement, and competition, and covers all stages of litigation including class certification, liability, and damages assessments. Mr. Darling received his M.B.A. at the MIT Sloan School of Management.

Tram Nguyen, PhD, Principal Consultant
Edgeworth Economics

Dr. Tram Nguyen specializes in quantitative economic analysis and modeling within the context of labor and employment discrimination matters, industrial organization, and firm management. She has extensive experience analyzing large and varied datasets, as well as expertise in machine learning and statistical tools.

Dr. Nguyen has provided support to clients on issues related to the economics of class certification for both direct and indirect purchaser classes and applying rigorous econometric analyses in estimating antitrust damages in dozens of matters. Her casework spans a broad range of industries, including agricultural products, railroads, chemicals, pharmaceuticals, and consumer products. Across these fields, Dr. Nguyen has extensive experience in leading teams of consultants to conduct empirical analysis of economic issues and present analytical insights in expert reports.

Dr. Nguyen earned her PhD and MA in economics from Stanford University.


David Shotlander, Partner

Haug Partners LLP

  • Discussion of relevant pharma antitrust cases and theories

Pavel Darling, Vice President

Analysis Group, Inc.

  • Discussion of merits and Rule 702 issues in those cases

Tram Nguyen, PhD, Principal Consultant

Edgeworth Economics

  • Discussion of class certification issues in those cases

Date & Time:

Tuesday, June 21, 2022

3:00 pm to 4:30 pm (ET)

Who Should Attend:

  • Antitrust Lawyers & Consultants
  • Healthcare Law Attorneys
  • M&A Lawyers and Consultants
  • Corporate Counsel
  • General Counsel
  • Executives from Healthcare and Life Sciences Industry
Preventing Ransomware Attacks: A Practical Guide to Enhancing IT Security and Resiliency,
Speaker Preferred Package (Online Payment)
Asbestos Litigation: Demystifying Trends, Developments, and Defense Strategies,
New York Online CLE Bundle
Pennsylvania Online CLE Bundle
California Online CLE Bundle
Supercharging Privilege Review With AI, Analytics, and Automation,
The Hows and Whys of Child Abuse Reporting: A Comprehensive Ethical Guide for Lawyers,
Understanding R&D Tax Credits and Amortization: Navigating Changes and Maximizing Benefits,
Maximizing Your Innovation ROI: R&D Tax Credits in 2024 and Beyond,
Winning Patent Litigation: Essential Strategies and Tactics,
Asbestos Litigation: What's Changing in 2024 and Beyond,
Cartel Investigations: A Blueprint for Defense,
Navigating the Evolving Patent Damages Landscape: Key Insights and Best Practices,
Demystifying Economic Sanctions: Strategies for Success in a Global Economy,
Antitrust 'No-Poach' Agreement Enforcement: Key Focus Areas in 2024,
Practical Trademark Perspectives from U.S. and Canadian Counsel,
Effectively Manage KYC Compliance: Keep Up with the Times by Getting Back to Basics,
OFAC Regulations and the Economic Sanctions Compliance Programs: Best Practices,
'Zombie' LIBOR for USD Contracts: Navigating the Critical Issues, ,
Calculating Lost Profits in Construction Claims: A Practical Guide,
False Claims Act and COVID-19 Implications: Key Considerations and Best Practices, ,


David ShotlanderPartner
Haug Partners LLP
Pavel DarlingVice President
Analysis Group, Inc.
Tram Nguyen, PhDPrincipal Consultant
Edgeworth Economics



View Details


View Details


View Details

Join Over 160,000 Professionals Empowering Their Careers

Learn anywhere from over 3000+ live and recorded CLE, CPE & Technology Webcasts.